Pharmaron Beijing Co., Ltd.
SZSE:300759.SZ
27.61 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,212.812 | 2,904.225 | 2,641.089 | 2,953.901 | 2,920.139 | 2,916.147 | 2,723.971 | 2,863.494 | 2,768.209 | 2,531.686 | 2,102.9 | 2,142.237 | 2,016.022 | 1,796.126 | 1,489.385 | 1,547.629 | 1,392.801 | 1,233.983 | 959.184 | 1,130.673 | 989.974 | 873.196 | 763.317 | 872.62 | 764.93 | 688.423 | 582.15 | 677.649 |
Cost of Revenue
| 2,097.585 | 1,999.423 | 1,798.592 | 1,992.027 | 1,891.331 | 1,842.017 | 1,749.005 | 1,796.173 | 1,689.763 | 1,604.683 | 1,407.272 | 1,401.864 | 1,270.454 | 1,120.469 | 972.067 | 977.619 | 837.871 | 756.362 | 638.223 | 678.663 | 632.399 | 599.535 | 512.186 | 575.469 | 512.729 | 502.348 | 386.212 | 473.331 |
Gross Profit
| 1,115.227 | 904.802 | 842.497 | 961.873 | 1,028.808 | 1,074.13 | 974.966 | 1,067.322 | 1,078.445 | 927.003 | 695.628 | 740.373 | 745.568 | 675.657 | 517.318 | 570.01 | 554.93 | 477.621 | 320.961 | 452.011 | 357.574 | 273.66 | 251.131 | 297.151 | 252.202 | 186.075 | 195.938 | 204.318 |
Gross Profit Ratio
| 0.347 | 0.312 | 0.319 | 0.326 | 0.352 | 0.368 | 0.358 | 0.373 | 0.39 | 0.366 | 0.331 | 0.346 | 0.37 | 0.376 | 0.347 | 0.368 | 0.398 | 0.387 | 0.335 | 0.4 | 0.361 | 0.313 | 0.329 | 0.341 | 0.33 | 0.27 | 0.337 | 0.302 |
Reseach & Development Expenses
| 124.455 | 105.348 | 93.606 | 144.007 | 114.585 | 105.34 | 76.839 | 104.856 | 93.799 | 44.022 | 39.647 | 41.923 | 45.388 | 35.369 | 29.095 | 36.298 | 25.943 | 22.155 | 20.949 | 19.899 | 16.285 | 17.994 | 8.693 | 8.084 | 8.973 | 8.083 | 6.471 | 5.456 |
General & Administrative Expenses
| 842.784 | -34.942 | 398.608 | -461.843 | 819.17 | -19.57 | 414.376 | -296.851 | 741.4 | 4.346 | 290.52 | -343.525 | 499.686 | -89.702 | 188.365 | -150.995 | 158.364 | -9.101 | 141.864 | -124.017 | 121.129 | -41.707 | 116.316 | -146.398 | 100.815 | -19.94 | 84.256 | -111.59 |
Selling & Marketing Expenses
| 164.406 | 67.482 | 55.468 | 58.86 | 67.142 | 71.08 | 55.697 | 67.031 | 54.93 | 61.285 | 46.824 | 51.235 | 40.648 | 31.67 | 32.063 | 27.415 | 24.806 | 22.53 | 17.892 | 26.615 | 17.607 | 16.012 | 12.754 | 20.342 | 10.99 | 13.35 | 10.068 | 17.375 |
SG&A
| 1,007.191 | 433.015 | 460.291 | 412.45 | 886.312 | 51.51 | 470.073 | -229.82 | 796.33 | 65.631 | 337.344 | -292.29 | 540.334 | -58.032 | 220.428 | -123.58 | 183.17 | 13.429 | 159.756 | -97.402 | 138.736 | -25.694 | 129.07 | -126.056 | 111.805 | -6.591 | 94.324 | -94.215 |
Other Expenses
| -528.699 | 0.253 | -0.254 | -6.47 | -46.604 | 44.035 | -1.731 | 743.238 | -333.911 | 351.805 | 4.87 | 210.507 | 83.652 | -86.495 | -0.609 | 75.568 | -0.281 | 86.642 | -4.261 | 1.276 | 5.87 | 0.163 | 1.86 | 15.415 | 3.902 | 0.591 | 0.554 | 9.507 |
Operating Expenses
| 602.946 | 538.11 | 554.151 | 562.927 | 571.888 | 589.327 | 545.18 | 618.275 | 556.218 | 461.458 | 381.862 | 339.231 | 324.358 | 250.547 | 239.923 | 265.462 | 201.259 | 187.831 | 184.39 | 170.366 | 162.336 | 150.883 | 146.649 | 152.461 | 127.868 | 100.659 | 107.044 | 90.158 |
Operating Income
| 397.992 | 366.692 | 288.347 | 398.946 | 414.606 | 482.306 | 431.572 | 466.888 | 373.418 | 428.877 | 320.066 | 708.318 | 536.343 | 386.583 | 283.093 | 426.06 | 361.183 | 417.695 | 118.896 | 263.666 | 185.225 | 120.899 | 61.697 | 112.282 | 124.404 | 96.114 | 46.797 | 85.886 |
Operating Income Ratio
| 0.124 | 0.126 | 0.109 | 0.135 | 0.142 | 0.165 | 0.158 | 0.163 | 0.135 | 0.169 | 0.152 | 0.331 | 0.266 | 0.215 | 0.19 | 0.275 | 0.259 | 0.338 | 0.124 | 0.233 | 0.187 | 0.138 | 0.081 | 0.129 | 0.163 | 0.14 | 0.08 | 0.127 |
Total Other Income Expenses Net
| -2.967 | 609.363 | -7.244 | 131.36 | -2.187 | -0.382 | -4.971 | -7.967 | 91.354 | -2.358 | -3.886 | 0.11 | 115.447 | -41.684 | 5.089 | 121.621 | 7.231 | 127.874 | -21.935 | -26.882 | -4.143 | 0.36 | -40.925 | -16.992 | 3.973 | 11.289 | -41.542 | -18.767 |
Income Before Tax
| 395.024 | 976.055 | 281.103 | 530.306 | 412.419 | 481.924 | 426.601 | 458.922 | 464.772 | 426.519 | 316.179 | 708.428 | 536.657 | 383.426 | 282.484 | 426.168 | 360.902 | 417.664 | 114.635 | 254.763 | 191.095 | 123.137 | 63.557 | 127.697 | 128.306 | 96.705 | 47.351 | 95.393 |
Income Before Tax Ratio
| 0.123 | 0.336 | 0.106 | 0.18 | 0.141 | 0.165 | 0.157 | 0.16 | 0.168 | 0.168 | 0.15 | 0.331 | 0.266 | 0.213 | 0.19 | 0.275 | 0.259 | 0.338 | 0.12 | 0.225 | 0.193 | 0.141 | 0.083 | 0.146 | 0.168 | 0.14 | 0.081 | 0.141 |
Income Tax Expense
| 108.764 | 91.205 | 52.699 | 69.686 | 61.963 | 48.003 | 76.454 | 50.963 | 85.894 | 98.171 | 79.227 | 92.28 | 80.029 | 72.799 | 45.812 | 45.404 | 61.31 | 44.205 | 21.459 | 41.549 | 30.317 | 18.767 | 11.245 | 19.163 | 20.002 | 14.563 | 7.712 | 20.08 |
Net Income
| 308.396 | 882.845 | 230.558 | 462.058 | 352.945 | 437.838 | 348.255 | 413.497 | 375.675 | 336.346 | 249.087 | 620.966 | 475.227 | 318.962 | 245.874 | 383.339 | 310.083 | 377.442 | 101.518 | 218.811 | 167.056 | 106.928 | 54.396 | 108.596 | 108.063 | 81.335 | 40.825 | 75.534 |
Net Income Ratio
| 0.096 | 0.304 | 0.087 | 0.156 | 0.121 | 0.15 | 0.128 | 0.144 | 0.136 | 0.133 | 0.118 | 0.29 | 0.236 | 0.178 | 0.165 | 0.248 | 0.223 | 0.306 | 0.106 | 0.194 | 0.169 | 0.122 | 0.071 | 0.124 | 0.141 | 0.118 | 0.07 | 0.111 |
EPS
| 0.17 | 0.5 | 0.13 | 0.26 | 0.3 | 0.25 | 0.2 | 0.23 | 0.47 | 0.43 | 0.21 | 0.78 | 0.6 | 0.4 | 0.21 | 0.49 | 0.26 | 0.48 | 0.086 | 0.33 | 0.17 | 0.17 | 0.057 | 0.18 | 0.12 | 0.14 | 0.046 | 0.13 |
EPS Diluted
| 0.17 | 0.5 | 0.13 | 0.26 | 0.2 | 0.25 | 0.2 | 0.23 | 0.47 | 0.43 | 0.21 | 0.78 | 0.6 | 0.4 | 0.21 | 0.49 | 0.26 | 0.48 | 0.086 | 0.33 | 0.17 | 0.17 | 0.057 | 0.18 | 0.12 | 0.14 | 0.046 | 0.13 |
EBITDA
| 450.192 | 644.098 | 366.779 | 662.396 | 421.087 | 568.041 | 449.07 | 650.224 | 404.263 | 552.087 | 311.638 | 806.243 | 530.155 | 429.335 | 333.625 | 474.819 | 312.294 | 396.973 | 157.134 | 261.889 | 215.16 | 142.939 | 84.9 | 214.81 | 206.332 | 117.89 | 64.524 | 160.152 |
EBITDA Ratio
| 0.14 | 0.222 | 0.139 | 0.224 | 0.144 | 0.195 | 0.165 | 0.227 | 0.146 | 0.218 | 0.148 | 0.376 | 0.263 | 0.239 | 0.224 | 0.307 | 0.224 | 0.322 | 0.164 | 0.232 | 0.217 | 0.164 | 0.111 | 0.246 | 0.27 | 0.171 | 0.111 | 0.236 |